Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment

Author(s): Melanie Heroult, Peter Ellinghaus, Stuart Ince, Matthias Ocker

Journal Name: Current Signal Transduction Therapy

Volume 9 , Issue 1 , 2014

Become EABM
Become Reviewer
Call for Editor


Growth factor signaling via receptor tyrosine kinases plays a central role in initiating and maintaining a malignant phenotype. Fibroblast growth factors (FGF) and their receptor family (FGFR1-4) are key players in various human solid and hematological tumors and have been linked to tumor cell proliferation, resistance to chemotherapy and apoptosis, angiogenesis, invasion and metastasis. FGFRs are commonly activated by genomic alterations or mutations and various approaches to targeted inhibition have been developed. The deeper understanding of the underlying signal transduction mechanisms has generated novel targeted therapy approaches like ligand-traps, receptor-specific antibodies or small molecule kinase inhibitors that are currently undergoing preclinical and clinical development for the treatment of human cancers.

Keywords: Fibroblast growth factor receptor, receptor tyrosine kinase, signal transduction inhibitor, targeted therapy.

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 23 September, 2014
Page: [15 - 25]
Pages: 11
DOI: 10.2174/157436240901140924103836

Article Metrics

PDF: 71